豁痰宽胸法联合立普妥对高脂血症患者血管黏附分子水平的影响  

Expectorant Enlarge Chest of TCM and Atorvastatin Influence Patient with Dyslipidemias on VCAM-1

作　　者：方居正[1] 

机构地区：[1]河南中医学院第一附属医院,郑州450000

出　　处：《中国中医急症》2008年第2期150-151,共2页Journal of Emergency in Traditional Chinese Medicine

摘　　要：目的观察高脂血症与血浆黏附分子(VCAM-1)水平的关系,观察宽胸化痰法对血管内皮损伤的治疗作用。方法113例高脂血症患者随机分为两组,均采用阿托伐他汀口服,治疗组加用豁痰宽胸中药;比较两组血脂水平与VCAM-1水平改善情况。结果两组VCAM-1及血脂水平治疗后明显改善,而治疗组改善程度优于对照组。结论豁痰宽胸中药联合阿托伐他汀降低血浆VCAM-1和血脂水平效果明显,可通过降低血脂以减少血管内皮损伤。Objective： To observe the expectorant enlarge chest of TCM in treating dyslipidemias and connection of dyslipidemias and VCAM - 1. Methods： 113 cases were divided into two groups at random, control group and treatment group. Both groups were treated with atorvastatin, and treatment group added TCM Medicine. The change of VCAM - 1 level and lipids level were compared. Results： The VCAM - 1 level of control group was higher than treatment group, but it was lower than preceding therapy. The treatment group was lower than preceding therapy too. The lipids level of control group were higher than treatment group, but they were lower than preceding therapy. Conclusion： Expectorant enlarge chest can decline the level of VCAM - 1 and the level of lipids.

关 键 词：高脂血症 血浆黏附因子 豁痰宽胸 

分 类 号：R589.2[医药卫生—内分泌]